2023
DOI: 10.1007/s11033-023-08322-7
|View full text |Cite
|
Sign up to set email alerts
|

Platelets and platelet-derived vesicles as an innovative cellular and subcellular platform for managing multiple sclerosis

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 85 publications
1
2
0
Order By: Relevance
“…They do so by affecting the activation and/or migration of leukocytes, endothelial cells, hematopoietic progenitor cells, and stem cells (34). Elevated expressions of CXCL9 and CXCL12 have been observed in various autoimmune diseases, including IBD, rheumatoid arthritis(35), Behcet's disease(36), and multiple sclerosis (37). These elevated expressions are positively correlated with disease activity and/or severity, which support the ndings of the study.…”
Section: Discussionsupporting
confidence: 66%
“…They do so by affecting the activation and/or migration of leukocytes, endothelial cells, hematopoietic progenitor cells, and stem cells (34). Elevated expressions of CXCL9 and CXCL12 have been observed in various autoimmune diseases, including IBD, rheumatoid arthritis(35), Behcet's disease(36), and multiple sclerosis (37). These elevated expressions are positively correlated with disease activity and/or severity, which support the ndings of the study.…”
Section: Discussionsupporting
confidence: 66%
“…PL-EVs are the most numerous EVs in the blood [77,78] and have shown immunomodulatory effects in endothelial cells, T cells and monocytes [79,80]. An increase in the number of PL-EVs and the presence of PL-EVs-Ig immunocomplexes (IC) has been reported in inflammatory conditions [81][82][83][84][85][86]. In systemic lupus erythematosus (SLE), PL-EVs showed increased levels of complement components and decreased TGF-β1 and lysosomalassociated membrane protein 1 (LAMP-1) [84,87].…”
Section: Plateletsmentioning
confidence: 99%
“…PMPs represent the most abundant MPs in human circulation [ 12 , 13 , 14 ]. Many studies have recognized the role of PMPs in hemostasis, thrombosis, cardiovascular disease, autoimmune diseases and cancer [ 15 , 16 , 17 , 18 , 19 ]. However, the role of PMPs in autoimmune diseases has not yet been reviewed in detail.…”
Section: Overview Of Pmpsmentioning
confidence: 99%